EUVIMEDEUVIMED entdecken
Open Access

Designing a quality assurance process for quality control of nuclear magnetic resonance metabolomics studies of human blood

Isabella H Muti, Matteo Gonzalez Sanchez-Dahl, Anya B Zhong, JianXiang Weng, Mark V Füzesi, Pia Kivisäkk, Bradley T Hyman, Steven E Arnold, Adam S Feldman, Nathaniel D Mercaldo, Leo L Cheng iD

NMR in Biomedicine · 2023-04 · 36 (4)

DOI: 10.1002/nbm.4868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NMR in Biomedicine, online erschienen am 12.12.2022. Verfasst von Isabella H Muti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Metabolomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High‐resolution magic angle spinning (HRMAS) nuclear magnetic resonance (NMR)‐based metabolomics has demonstrated its utility in studies of biofluids for various diseases. HRMAS NMR spectroscopy is uniquely well suited for analyzing human blood samples because of the small quantity of samples and minimal preparation required. To develop this methodology into standardized clinical protocols, establishment of the method's quality assurance (QA) and evaluations of its quality control (QC) are critical. This study aims to assess the QA/QC measured from human blood specimens in the form of serum and plasma through within‐subject and between‐subject comparisons, as well as stability and consistency comparisons over several freezing–thawing cycles of sample storage conditions, and most importantly, the agreement of pooled control samples against individual samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingMetabolomicsHumansMagnetic Resonance Spectroscopy

Stichwörter der Autor:innen

metabolomicsnuclear magnetic resonancequality assurancequality controlspectroscopy

Autor:innen und Institutionen

  • Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Leo L Cheng

Förderung

  • NCI NIH HHS
  • NIA NIH HHS
  • NIH HHS
  • Massachusetts General Hospital
  • National Institutes of Health

Zitieren

APA

Muti, I. H., Gonzalez Sanchez-Dahl, M., Zhong, A. B., Weng, J., Füzesi, M. V., Kivisäkk, P., Hyman, B. T., Arnold, S. E., Feldman, A. S., Mercaldo, N. D., & Cheng, L. L. (2023). Designing a quality assurance process for quality control of nuclear magnetic resonance metabolomics studies of human blood. NMR in Biomedicine, 36(4). https://doi.org/10.1002/nbm.4868

Vancouver

Muti IH, Gonzalez Sanchez-Dahl M, Zhong AB, Weng J, Füzesi MV, Kivisäkk P, et al. Designing a quality assurance process for quality control of nuclear magnetic resonance metabolomics studies of human blood. NMR in Biomedicine. 2023;36(4). doi:10.1002/nbm.4868

BibTeX
@article{Muti2023,
  author = {Muti, Isabella H and Gonzalez Sanchez-Dahl, Matteo and Zhong, Anya B and Weng, JianXiang and Füzesi, Mark V and Kivisäkk, Pia and Hyman, Bradley T and Arnold, Steven E and Feldman, Adam S and Mercaldo, Nathaniel D and Cheng, Leo L},
  title = {Designing a quality assurance process for quality control of nuclear magnetic resonance metabolomics studies of human blood},
  journal = {NMR in Biomedicine},
  year = {2023},
  volume = {36},
  number = {4},
  doi = {10.1002/nbm.4868}
}
Kostenlos starten →